CRBP SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001716774-26-000025
CRBP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 29, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.7% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Corbus Pharmaceuticals Holdings, Inc. The filing indicates a change in the holder's previously reported beneficial ownership.
Key details
How CRBP stock reacted
Close before
$4.25
Oct 28, 2026
First close after
-0.71%
$4.22
5 trading days
-16.00%
$3.57
Since filing
-27.76%
$3.07
✦ Ask GOAX AI about this filing — what it means for CRBP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRBP?
Click hereFrequently asked questions
What did CRBP file with the SEC on Oct 29, 2026?
CRBP filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Corbus Pharmaceuticals Holdings, Inc. The filing indicates a change in the holder's previously reported beneficial ownership.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CRBP stock react to this filing?
CRBP closed at $4.25 before the filing and $4.22 on Oct 29, 2026 (-0.71%). Five trading days later: $3.57 (-16.00%).
Other CRBP SEC filings
- SCHEDULE 13G/A · SEC filingNov 2, 2026
- 8-K · SEC filingOct 15, 2026
- SCHEDULE 13G · SEC filingSep 30, 2026
- 8-K · Fda approvalSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 424B5 · Secondary offeringAug 7, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Executive departureJul 6, 2026
- 8-K · SEC filingMay 26, 2026
Get alerts when CRBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days